News InnoCan Pharma Corporation

Equities

INNO

CA45783P1027

Delayed Canadian Securities Exchange Other stock markets 09:47:33 2023-12-07 am EST			5-day change	1st Jan Change
0.3 ^CAD	-3.23%		-11.76%	+39.53%

Nov. 29	InnoCan Pharma Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
Nov. 29	InnoCan Pharma Brief: Says "Surge" in revenue Primarily attributable to "Robust" sales performance of Subsidiary, B.I. Sky Global Ltd.	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

InnoCan Pharma Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 29	CI
InnoCan Pharma Brief: Says "Surge" in revenue Primarily attributable to "Robust" sales performance of Subsidiary, B.I. Sky Global Ltd.	Nov. 29	MT
InnoCan Pharma Brief: Reporting US$4.083 Million In Revenues for Q3 2023 Vs US$749,000 for Q3 2022, representing an increase of 445%	Nov. 29	MT
Innocan Pharma Reports Q3 2023 Results Including US$3.334M Increase in Revenues Compared to Q3, 2022	Nov. 29	AQ
Innocan Pharma Corporation Announces Promising LPT-CBD Safety Indications	Nov. 03	CI
Innocan Pharma Announces Promising LPT-CBD Safety Indications -Implications from a prolong use in animals	Nov. 03	AQ
Innocan Pharma reports a groundbreaking discovery regarding its LPD platform and global CBD research	Oct. 23	AQ
InnoCan Pharma Completes Second, Final Tranche of Financing; Down Over 3%	Oct. 20	MT
Innocan Pharma Announces Closing of Second and Final Tranche of Financing	Oct. 20	AQ
InnoCan Pharma Corporation announced that it has received CAD 1.627682 million in funding	Oct. 19	CI
InnoCan Pharma Completes First Tranche Private Placement; Down 4.8%	Oct. 12	MT
Innocan Pharma Announces Closing of First Tranche Private Placement and Provides Corporate Update	Oct. 12	AQ
Innocan Pharma Plans Brokered LIFE Offering of Units for Nearly $3 Million	Sep. 21	MT
Innocan Pharma Announces Brokered LIFE Offering of Units for Up to $3 Million	Sep. 21	GL
InnoCan Pharma Corporation announced that it expects to receive CAD 3 million in funding	Sep. 20	CI
InnoCan Pharma Corporation Announces Appointment of Dr. Joseph V. Pergolizzi to its Scientific Advisory Board	Sep. 15	CI
Innocan Pharma Announces the Addition of Dr. Joseph V. Pergolizzi, Jr., M.D. to its Advisory Board	Sep. 15	AQ
Innocan Pharma Corporation Announces Promising Results from Hair Care Cream Efficacy Test	Sep. 05	CI
Innocan Pharma Announces Promising Results from Hair Care Cream Efficacy Test	Sep. 05	AQ
Innocan Pharma Announces Clinical Study Results: Evidence of Reduced Osteoarthritis Pain in Dogs After Liposomal CBD Injection	Aug. 29	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies

News InnoCan Pharma Corporation

Equities

INNO

CA45783P1027

Summary

Filters